Archives
-
mCherry mRNA as a Translational Delivery Benchmark
2026-09-02
Cap 1-capped, modified mCherry mRNA can serve as more than a fluorescence reporter: it can become a practical benchmark for delivery, translation, and immune-compatibility decisions in translational workflows.
-
HyperScribe T7 High Yield Cy5 RNA Labeling Kit Guide
2026-09-02
Build bright, customizable RNA probes for in situ hybridization, Northern analysis, and RNA-delivery tracking with a workflow that balances transcript yield against Cy5 density. This practical guide explains template preparation, Cy5-UTP optimization, quality control, and troubleshooting for reproducible fluorescent RNA probe synthesis.
-
HBTU Workflows for Responsive Peptide Design
2026-09-01
HBTU combines mild carboxylic acid activation with practical compatibility for solid phase peptide synthesis, making it useful for assembling enzyme-responsive peptide amphiphiles and larger sequences. This guide connects coupling chemistry to assay-ready design while separating synthesis recommendations from the biological evidence reported for dual enzyme-responsive cancer-selective peptides.
-
Mianserin HCl: From Receptor Biology to Translation
2026-09-01
A mechanism-first analysis of Mianserin HCl for receptor pharmacology, psychiatric disorder research, and carefully bounded antipathogenic translation.
-
A-1155463: A Selective BCL-XL Inhibitor
2026-08-31
Explore how the BCL-XL inhibitor A-1155463 converts apoptotic priming into an experimentally testable cancer vulnerability. This guide connects its biochemical profile with glioblastoma findings and practical assay decisions without overstating preclinical evidence.
-
Rapamycin in mTORC1 Lipotoxicity Research
2026-08-31
Rapamycin (Sirolimus) is a precise mTOR pathway probe for connecting nutrient stress with hepatocyte injury. This guide translates recent NAD⁺–PARP-1–mTORC1 findings into practical assay design, controls, and interpretation strategies.
-
5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB)
2026-08-30
DRB provides a temporally controlled way to interrogate transcriptional elongation, CTD kinase activity, and downstream RNA-processing phenotypes. This workflow shows how to connect DRB perturbation with modern RNA-interaction and translation assays while avoiding dose, solubility, and interpretation traps.
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-08-29
Saito and colleagues developed a direct three-dimensional cluster-culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The resulting organoids could be propagated, cryopreserved, and differentiated into epithelial cells containing enterocytes with cytochrome P450 and transporter activities relevant to oral drug absorption and metabolism.
-
ARCA EGFP mRNA: From Control to Decision Tool
2026-08-28
ARCA EGFP mRNA provides a direct fluorescence readout for evaluating delivery and mammalian cell gene expression. This article presents a decision-centered framework for using reporter signal to distinguish transfection failure from downstream expression limits, with practical insight from a synthetic mRNA host-directed therapy study.
-
MiR-24-3p in Doxorubicin-Induced Heart Failure
2026-08-28
The reference study identifies miR-24-3p as a harmful upstream regulator of the Sp1/PI3K pathway in doxorubicin-induced heart failure. By combining rat and H9c2 cell models with molecular, functional, and target-validation assays, it shows that silencing miR-24-3p reduces apoptosis and oxidative stress while improving cardiac injury phenotypes.
-
EVMPs Enable Extrahepatic IL-12 mRNA Delivery
2026-08-27
Yu and colleagues developed a self-assembling enveloped virus-mimicking particle that combines engineered peptides with selected phospholipids for organ-targeted mRNA delivery beyond the liver. The optimized system transfected lung endothelial and immune cells and, when loaded with IL-12 mRNA, suppressed tumor progression in a metastatic lung tumor model while retaining a low-immunogenicity profile suitable for repeat administration.
-
Capsaicin: TRPV1, LSD1, and Assay Design
2026-08-27
Capsaicin research extends beyond TRPV1 ion channel activation to KDM1A/LSD1 inhibition and cancer-cell phenotyping. This guide presents an orthogonal assay strategy, practical parameters, and translational limitations for studying (E)-Capsaicin in pain, inflammation, dermatitis, and gastric cancer models.
-
DAPT (GSI-IX) for Notch-Driven Angiogenesis
2026-08-26
DAPT (GSI-IX) is a selective γ-secretase inhibitor that can reveal how Notch signaling influences endothelial migration, vessel formation, and ischemic repair. This article translates a critical limb ischemia study into practical, causally informed assay decisions.
-
Firefly Luciferase mRNA as a Delivery Control
2026-08-26
Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP) is more than a sensitive reporter: it can reveal how delivery, RNA engineering, and cell state shape experimental outcomes. This article connects its molecular design to practical gene expression, viability, and imaging decisions.
-
5-Methyl-CTP for Robust mRNA Synthesis
2026-08-25
5-Methyl-CTP provides a practical route to test cytidine methylation during in vitro transcription, with potential benefits for transcript persistence and protein output. This guide connects reagent handling and assay optimization with emerging delivery workflows, including engineered outer membrane vesicles for personalized mRNA vaccines.